Correlation Between Molecular Partners and Tff Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Molecular Partners and Tff Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Molecular Partners and Tff Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Molecular Partners AG and Tff Pharmaceuticals, you can compare the effects of market volatilities on Molecular Partners and Tff Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Molecular Partners with a short position of Tff Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Molecular Partners and Tff Pharmaceuticals.
Diversification Opportunities for Molecular Partners and Tff Pharmaceuticals
-0.05 | Correlation Coefficient |
Good diversification
The 3 months correlation between Molecular and Tff is -0.05. Overlapping area represents the amount of risk that can be diversified away by holding Molecular Partners AG and Tff Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tff Pharmaceuticals and Molecular Partners is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Molecular Partners AG are associated (or correlated) with Tff Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tff Pharmaceuticals has no effect on the direction of Molecular Partners i.e., Molecular Partners and Tff Pharmaceuticals go up and down completely randomly.
Pair Corralation between Molecular Partners and Tff Pharmaceuticals
Given the investment horizon of 90 days Molecular Partners AG is expected to generate 0.72 times more return on investment than Tff Pharmaceuticals. However, Molecular Partners AG is 1.39 times less risky than Tff Pharmaceuticals. It trades about 0.02 of its potential returns per unit of risk. Tff Pharmaceuticals is currently generating about -0.07 per unit of risk. If you would invest 670.00 in Molecular Partners AG on September 2, 2024 and sell it today you would lose (88.00) from holding Molecular Partners AG or give up 13.13% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Molecular Partners AG vs. Tff Pharmaceuticals
Performance |
| Timeline |
| Molecular Partners |
| Tff Pharmaceuticals |
Molecular Partners and Tff Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Molecular Partners and Tff Pharmaceuticals
The main advantage of trading using opposite Molecular Partners and Tff Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Molecular Partners position performs unexpectedly, Tff Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tff Pharmaceuticals will offset losses from the drop in Tff Pharmaceuticals' long position.| Molecular Partners vs. Tff Pharmaceuticals | Molecular Partners vs. Eliem Therapeutics | Molecular Partners vs. Inhibrx | Molecular Partners vs. Enliven Therapeutics |
| Tff Pharmaceuticals vs. Gain Therapeutics | Tff Pharmaceuticals vs. In8bio Inc | Tff Pharmaceuticals vs. Lantern Pharma | Tff Pharmaceuticals vs. INmune Bio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Other Complementary Tools
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| CEOs Directory Screen CEOs from public companies around the world |